MedTrace Logo

Standard of Care Versus Hemopatch® During Liver Resection

NCT03166683 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 284

Last updated 2017-11-09

No results posted yet for this study

Summary

This multicentre prospective and randomized study aims to compare the sealant effect after surgical liver resection of a new collagen - polyethylene glycol hemostatic / sealant patch (Hemopatch) vs standard of care.

Conditions

  • Liver Cancer
  • Hemorrhage Liver
  • Bile Leak
  • Surgery
  • Tumor Liver

Interventions

OTHER

Hemopatch

Liver resection surgery with collagen and polyethylene glycol haemostatic/sealant patch placement

OTHER

Standard of care

Standard of care include other sealant / hemostatic devices as patches or liquid/gels

Sponsors & Collaborators

  • Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

    lead OTHER

Principal Investigators

  • Miguel Angel Gómez Bravo, PhD · Hospitales Universitarios Virgen del Rocío

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-31
Primary Completion
2020-04-30
Completion
2020-09-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03166683 on ClinicalTrials.gov